Benefit-risk assessment of acne therapies.
Seukeran
D C
DC
Eady
E A
EA
Cunliffe
W J
WJ
D000152:Acne Vulgaris / Q000188:drug therapy*; D000279:Administration, Cutaneous; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D016903:Drug Monitoring; D006801:Humans; D008099:Liver / Q000187:drug effects; D008911:Minocycline / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D012306:Risk; D018570:Risk Assessment
D000900:Anti-Bacterial Agents; D008911:Minocycline